Validation of an algorithm to prioritize patients for comprehensive medication management in primary care settings
Background Comprehensive medication management (CMM) programs optimize the effectiveness and safety of patients’ medication regimens, but CMM may be underutilized. Whether healthcare claims data can identify patients appropriate for CMM is not well-studied. Aim Determine the face validity of a claim...
Saved in:
| Published in | International journal of clinical pharmacy Vol. 46; no. 5; pp. 1232 - 1236 |
|---|---|
| Main Authors | , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Cham
Springer International Publishing
01.10.2024
Springer Springer Nature B.V |
| Subjects | |
| Online Access | Get full text |
| ISSN | 2210-7703 2210-7711 2210-7711 |
| DOI | 10.1007/s11096-024-01770-6 |
Cover
| Summary: | Background
Comprehensive medication management (CMM) programs optimize the effectiveness and safety of patients’ medication regimens, but CMM may be underutilized. Whether healthcare claims data can identify patients appropriate for CMM is not well-studied.
Aim
Determine the face validity of a claims-based algorithm to prioritize patients who likely need CMM.
Method
We used claims data to construct patient-level markers of “regimen complexity” and “high-risk for adverse effects,” which were combined to define four categories of claims-based CMM-need (very likely, likely, unlikely, very unlikely) among 180 patient records. Three clinicians independently reviewed each record to assess CMM need. We assessed concordance between the claims-based and clinician-review CMM need by calculating percent agreement as well as kappa statistic.
Results
Most records identified as ‘very likely’ (90%) by claims-based markers were identified by clinician-reviewers as needing CMM. Few records within the ‘very unlikely’ group (5%) were identified by clinician-reviewers as needing CMM. Interrater agreement between CMM-based algorithm and clinician review was moderate in strength (kappa = 0.6,
p
< 0.001).
Conclusion
Claims-based pharmacy measures may offer a valid approach to prioritize patients into CMM-need groups. Further testing of this algorithm is needed prior to implementation in clinic settings. |
|---|---|
| Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 |
| ISSN: | 2210-7703 2210-7711 2210-7711 |
| DOI: | 10.1007/s11096-024-01770-6 |